Cellspect

Morioka, Japan · Founded 2014 · Privately Held (backing)

Developer of in-vitro diagnostic agents and medical devices designed to offer the prognosis of endometriosis progression. Cellspect is based in Morioka, Japan and was founded in 2014. Its last reported valuation was $142 million in May 2019. It has raised $22.6 million.

Last reported valuation
$142.1M
Oct 2026
Priced at
—
Total raised
$22.6M
Last round
—

Who backs Cellspect?

15 investors
InvestorType
Mitsubishi UFJ CapitalOther
FASTAROther
MCP PartnersOther
Tokyo University of Science Investment ManagementOther
Aflac Ventures Japan—
Business Creation Capital—
DBJ Regional Investment—
Iwagin Jigyo Souzou Capital—
Jameel Trading—
MCP Capital—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Cellspect investors

15 investors are on record for Cellspect, including Mitsubishi UFJ Capital, FASTAR, MCP Partners and Tokyo University of Science Investment Management.

Free account
More of Cellspect with a free account
  • ·The complete investor list: 15 names
  • ·Watch Cellspect: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Cellspect. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View